Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / AVCNF - CBD Helps With This Rare Blistering Skin Disorder New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment | Benzinga


AVCNF - CBD Helps With This Rare Blistering Skin Disorder New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment | Benzinga

There is no cure for a rare blistering skin disorder called Epidermolysis Bullosa (EB), but treatments to help alleviate and control the symptoms do exist.  

The growing body of research suggests cannabinoid-based medicines can ease the pain and severe itching in those with this disorder while also improving healing.

Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), a biopharma company focused on the development and commercialization of plant-derived CBD products announced it has completed a retrospective observational real-world study using its RHO Phyto branded Ultra CBD Topical Cream, an oil-based 3% CBD localized cream on patients ...

Full story available on Benzinga.com

Stock Information

Company Name: Avicanna Inc
Stock Symbol: AVCNF
Market: OTC
Website: avicanna.com

Menu

AVCNF AVCNF Quote AVCNF Short AVCNF News AVCNF Articles AVCNF Message Board
Get AVCNF Alerts

News, Short Squeeze, Breakout and More Instantly...